Abbott Laboratories

Healthcare · Medical Devices

102.60$ +0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Abbott Laboratories (ABT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 44,328 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ABT
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	11,013	11,883	12,478	13,178	13,746	16,285	17,685	19,681	19,680	22,338	22,476	25,914	29,528	30,765	35,167	38,851	39,874	21,848	20,247	20,405	20,853	27,390	30,578	31,904	34,608	43,075	43,653	40,109	41,950	44,328
Cost of Revenue	4,732	5,046	5,394	5,977	6,239	7,748	8,506	9,473	8,884	10,467	9,634	11,328	12,483	13,145	14,573	15,411	10,640	9,800	9,757	9,445	9,609	14,324	14,755	15,211	17,231	19,861	21,330	20,072	20,625	19,721
Gross Profit	6,281	6,838	7,083	7,200	7,507	8,537	9,178	10,207	10,796	11,871	12,842	14,586	17,045	17,619	20,594	23,441	10,854	9,857	10,490	10,960	11,244	13,066	15,823	16,693	17,377	23,214	22,323	20,037	21,325	24,607
Research & Development	1,205	1,302	1,222	1,194	1,351	1,578	1,562	1,733	1,697	1,811	2,226	2,403	2,689	2,744	3,572	4,060	1,544	1,371	1,286	1,369	1,358	2,130	2,288	2,408	2,418	2,738	2,852	2,719	2,823	2,955
Selling, General & Administrative	2,460	2,685	2,744	2,857	2,894	3,735	3,979	5,051	4,922	5,496	6,350	7,408	8,436	8,406	10,376	12,757	12,059	6,936	6,530	6,785	6,672	9,117	9,744	9,765	9,696	11,324	11,012	11,198	11,697	12,378
Total Operating Expenses	3,664	3,987	3,965	4,051	4,245	6,643	5,541	6,784	6,619	7,221	8,506	9,641	10,955	11,049	13,543	16,599	8,847	7,711	7,574	8,011	7,995	11,094	11,979	12,102	12,086	14,014	13,961	13,602	14,474	16,586
Operating Income	2,617	2,850	3,118	3,149	3,401	1,894	3,152	2,974	4,177	4,649	4,336	4,946	6,089	6,571	7,051	6,841	2,007	2,146	2,916	2,949	3,249	1,972	3,844	4,591	5,291	9,200	8,362	6,435	6,825	8,048
Interest Expense	0.0	0.0	0.0	0.0	23	234,759	205	146	200	241	416	593	528	211	801	1,018	409	47	164	178	304	880	729	818	708	410	315	698	603	341
Pre-Tax Income	2,670	2,950	3,241	3,397	3,816	1,883	3,673	3,734	4,126	4,620	2,276	4,470	5,856	7,194	5,713	5,199	6,263	2,521	2,518	3,183	1,413	2,231	2,873	4,077	4,968	8,211	8,306	6,664	7,013	8,466
Income Tax Expense	788	855	907	951	1,030	333	880	981	950	1,248	560	863	1,122	1,448	1,087	470	300	138	797	577	350	1,878	539	390	497	1,140	1,373	941	-6,389	1,942
Net Income	1,882	2,079	2,334	2,446	2,786	1,550	2,794	2,753	3,236	3,372	1,717	3,606	4,881	5,746	4,626	4,728	5,963	2,576	2,284	4,423	1,400	477	2,368	3,687	4,495	7,071	6,933	5,723	13,402	6,524
EBITDA	3,303	3,563	3,904	3,977	4,228	4,392	4,303	4,202	5,615	6,220	4,251	6,918	8,224	9,494	9,138	9,261	3,496	3,604	4,155	4,833	3,070	6,132	6,880	7,909	9,003	12,159	11,888	10,605	10,834	11,553

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings